LUV.png
Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study
30 nov. 2021 08h50 HE | Love Pharma Inc.
NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to...
W2Email Logo.jpg
Way2Grow (W2G) Biopharma Corp. Receives Health Canada Approval Notice for Construction of a Controlled Substances Dealer’s Licence Level 8 Psychedelic Secure Environ and Psilocybin Production Campus
17 nov. 2021 07h30 HE | Way2Grow Biopharma Corp.
OSOYOOS, British Columbia, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Way2Grow Biopharma Corp. (“W2G” or the “Company”), a privately held therapeutic corporation existing under the laws...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Matt Stang, CEO of Delic Holdings Corp.
16 nov. 2021 08h17 HE | InvestorBrandNetwork (IBN)
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) to Serve as Media Sponsor for the Upcoming Lift&Co. Expo on Nov. 18-21, 2021
10 nov. 2021 09h35 HE | InvestorBrandNetwork (IBN)
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, is pleased to announce today that it will be...
Microdose Psychedelic Insights Provides an Update on the Upcoming Wonderland: Miami Conference, Shares Details on Newly Confirmed Participants and Unmissable Fireside Chats
06 nov. 2021 14h55 HE | Microdose Psychedelic Insights
NEW YORK, Nov. 06, 2021 (GLOBE NEWSWIRE) -- via PsychedlicNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis and engaging...
LUV.png
LOVE Pharma Announces Debut of New Products, BLOOM™ and AURALIEF™
27 oct. 2021 07h00 HE | Love Pharma Inc.
VANCOUVER, BC CANADA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- LOVE Pharma Co. (CSE: LUV) (FSE: G1Q0), the Company is pleased to announce the debut of its first two products, BLOOM™ and AURALIEF™. ...
Woven Science's El Puente Releases Its Policy Paper on Indigenous Reciprocity & Corporate Social Responsibility
19 oct. 2021 10h00 HE | Woven Science
NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Woven Science's El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for Upcoming Psychedelic Capital Conference
15 oct. 2021 09h35 HE | InvestorBrandNetwork (IBN)
NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be collaborating with...
Picture1.jpg
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE | Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
LUV.png
Love Pharma Makes Public Debut in Emerging Sexual Health, Wellness, and Psychedelics Markets
04 oct. 2021 08h45 HE | Love Pharma Inc.
NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a new-age pharma/nutraceutical company that specializes in the global sexual...